Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046449 · ClinicalTrials.gov registry record · Phase 3
Prevention of Seasonal Affective Disorder
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00046449 is a Phase 3 study that has completed, run by GlaxoSmithKline.
The verdict
NCT00046449, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder
Interventions
- DRUG Investigational Seasonal Affective Disorder (SAD) Drug
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-09 |
| Est. Completion | 2003-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00046449
The ClinicalTrials.gov registry entry for NCT00046449 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Investigational Seasonal Affective Disorder (SAD) Drug is the first listed.
NCT00046449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00046449 about?
NCT00046449 is a clinical study titled "Prevention of Seasonal Affective Disorder". A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder
What is the current status of trial NCT00046449?
This trial is currently completed. It is a Phase 3 study. The study started on 2002-09. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00046449?
The interventions under investigation include: Investigational Seasonal Affective Disorder (SAD) Drug (DRUG).
Who is sponsoring clinical trial NCT00046449?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.